Protein Folding

J. Frydman, E. Nimmesgern, K. Ohtsuka, F.U. Hartl, "Folding of nascent polypeptide chains in a high molecular mass assembly with molecular chaperones," Nature, 370:111-7, 1994. (Cited in nearly 50 publications through September) Comments by Judith Frydman and F. Ulrich Hartl, Memorial Sloan-Kettering Cancer Center, New York This paper describes a series of experiments "analyzing how polypeptide chains fold to their final shapes when being synthesized," according to F. Ulrich Hartl, a member o

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

J. Frydman, E. Nimmesgern, K. Ohtsuka, F.U. Hartl, "Folding of nascent polypeptide chains in a high molecular mass assembly with molecular chaperones," Nature, 370:111-7, 1994. (Cited in nearly 50 publications through September)

Comments by Judith Frydman and F. Ulrich Hartl, Memorial Sloan-Kettering Cancer Center, New York

This paper describes a series of experiments "analyzing how polypeptide chains fold to their final shapes when being synthesized," according to F. Ulrich Hartl, a member of the cellular biochemistry and biophysics program at New York City-based Memorial Sloan-Kettering Cancer Center, and a Howard Hughes Medical Institute associate investigator there.

Frydman and Hartl KNOWING WHEN TO FOLD: Judith Frydman and F. Ultrich Hartl tested a hypothesis concerning protein folding.

Using the folding of the protein luciferase from fireflies as a model, the researchers "attempted to answer two main questions: first, whether molecular chaperones were involved in protein folding during translation; and second, which chaperone systems participated in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies